Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS in Smoking Cessation (TabacStim2)
NCT04591743Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jun 2020
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Continuous Abstinence Rate at 12 months. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04591743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591743.